ClinicalTrials.Veeva

Menu

Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections

T

Tampere University

Status

Completed

Conditions

Respiratory Tract Infections

Treatments

Dietary Supplement: vitamin D
Dietary Supplement: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT00973583
UTampere-RO5125

Details and patient eligibility

About

The investigators earlier clinical study in 754 young Finnish men demonstrated a significant negative association of serum 25-OHD concentration with acute respiratory tract infections. The present study aimed to determine whether vitamin D supplementation may decrease the incidence of acute respiratory tract infections.

Full description

Subjects comprised 164 male conscripts at a military base in Finland. Half of the participants were randomly allocated to receive 400 IU vitamin D daily and half received placebo from October through March. Serum vitamin D and plasma parathyroid hormone concentrations were determined. Subjects were followed for 6 months and the primary outcome was the number of days absent from duty due to ARTI.

Enrollment

164 patients

Sex

Male

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Exclusion Criteria:

  • Use vitamin D

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

164 participants in 2 patient groups, including a placebo group

vitamin D
Active Comparator group
Treatment:
Dietary Supplement: vitamin D
placebo
Placebo Comparator group
Treatment:
Dietary Supplement: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems